IHH Q0F

SGD 2.50 +2.80% +0.07 Updated 13 Nov 2026, 17:16 SGT

Company profile

The business, the people and the ownership behind IHH.

Business overview

About the company

IHH Healthcare operates hospitals and healthcare services across international markets, including Singapore, Malaysia, India, Greater China, Türkiye and Europe. Its group interests also include laboratories and Parkway Life REIT.

Annual Report 2025 ↗ Reviewed 2026-10-23 · Source dated 2026-04-24. PDF p. 50

Listed security

Company & listing

Full Company Name
IHH HEALTHCARE BERHAD
Trading Currency
SGD
Website
http:// www.ihhhealthcare.com
Listing
Listed on 25 July 2012 on MAINBOARD
ISIN Code
MYL5225OO007

Board & management

Leadership

Board profiles disclose11current directors and2alternate directors as at31March2026. Lim Tsin-Lin resigned on17September2025 and is retained separately as a former director.

CEO,CFO and country leadership roles are distinguished. The76,000employee team figure is stated in the CEO profile; it is not presented as audited full-time year-end headcount.

Director names follow each source: board profile Christine Li Shuling and ownership register Li Shuling, Christine identify the same named alternate director, but the original source wording is retained.

Telephone and fax digits retain the exact source; whitespace is normalized for display.

Tan Sri Dr Nik Norzrul Thani bin N Hassan Thani

Chairman, Independent, Non-Executive

Board profiles as at31March2026 in FY2025 annual report

Tan Sri Dr Nik Norzrul Thani bin N Hassan Thani — board appointment

26 June 2024

As disclosed in FY2025 annual report

Jill Margaret Watts

Independent, Non-Executive

Board profiles as at31March2026 in FY2025 annual report

Jill Margaret Watts — board appointment

4 April 2018

As disclosed in FY2025 annual report

Dato’ Sri Muthanna bin Abdullah

Independent, Non-Executive

Board profiles as at31March2026 in FY2025 annual report

Dato’ Sri Muthanna bin Abdullah — board appointment

1 January 2021

As disclosed in FY2025 annual report

Satoshi Tanaka

Independent, Non-Executive

Board profiles as at31March2026 in FY2025 annual report

Satoshi Tanaka — board appointment

1 January 2021

As disclosed in FY2025 annual report

Chua Bin Hwee

Independent, Non-Executive

Board profiles as at31March2026 in FY2025 annual report

Chua Bin Hwee — board appointment

14 August 2024

As disclosed in FY2025 annual report

Tan Wah Yeow

Independent, Non-Executive

Board profiles as at31March2026 in FY2025 annual report

Tan Wah Yeow — board appointment

17 September 2025

As disclosed in FY2025 annual report

Yoichiro Endo

Non-Independent, Non-Executive

Board profiles as at31March2026 in FY2025 annual report

Yoichiro Endo — board appointment

1 April 2024

As disclosed in FY2025 annual report

Tomo Nagahiro

Non-Independent, Non-Executive

Board profiles as at31March2026 in FY2025 annual report

Tomo Nagahiro — board appointment

3 February 2023

As disclosed in FY2025 annual report

Mohd Shahazwan bin Mohd Harris

Non-Independent, Non-Executive

Board profiles as at31March2026 in FY2025 annual report

Mohd Shahazwan bin Mohd Harris — board appointment

29 March 2023

As disclosed in FY2025 annual report

Mehmet Ali Aydinlar

Non-Independent, Non-Executive

Board profiles as at31March2026 in FY2025 annual report

Mehmet Ali Aydinlar — board appointment

24 January 2012

As disclosed in FY2025 annual report

Shahida binti Mohd Jaffar Sadiq Maricar

Non-Independent, Non-Executive

Board profiles as at31March2026 in FY2025 annual report

Shahida binti Mohd Jaffar Sadiq Maricar — board appointment

17 September 2025

As disclosed in FY2025 annual report

Mok Jia Mei

Non-Independent, Non-Executive; Alternate Director to Mohd Shahazwan bin Mohd Harris

Board profiles as at31March2026 in FY2025 annual report

Mok Jia Mei — board appointment

17 September 2025

As disclosed in FY2025 annual report

Christine Li Shuling

Non-Independent, Non-Executive; Alternate Director to Yoichiro Endo

Board profiles as at31March2026 in FY2025 annual report

Christine Li Shuling — board appointment

6 March 2025

As disclosed in FY2025 annual report

Dr Prem Kumar Nair

Group Chief Executive Officer

As disclosed in FY2025 annual report

Dilip Kadambi

Group Chief Financial Officer

As disclosed in FY2025 annual report

Ashok Pandit

Group Chief Corporate Officer

As disclosed in FY2025 annual report

Adjunct Associate Professor Keith Lim Hsiu Chin

Group Chief Medical Officer

As disclosed in FY2025 annual report

Sharon Foo Sook Yean

Group Chief Human Resource Officer

As disclosed in FY2025 annual report

Ida Suryati Ab. Rahim

Group General Counsel

As disclosed in FY2025 annual report

Stephen Byrne

Group Chief Internal Audit Officer

As disclosed in FY2025 annual report

Nili Shayrina binti Saat

Group Chief Risk Officer

As disclosed in FY2025 annual report

Seow Ching Voon

Company Secretary

As disclosed in FY2025 annual report

Dr Kamal Amzan

Chief Executive Officer, IHH Healthcare Malaysia

As disclosed in FY2025 annual report

Dr Peter Chow

Chief Executive Officer, IHH Healthcare Singapore

As disclosed in FY2025 annual report

Dr Kenneth Tsang

Regional Chief Executive Officer, IHH Healthcare North Asia

As disclosed in FY2025 annual report

Dr Ashutosh Raghuvanshi

Managing Director & Chief Executive Officer, Fortis Healthcare

As disclosed in FY2025 annual report

Uğur Genç

Chief Executive Officer, Acibadem Sağlık Yatırımlar Holding A.S

As disclosed in FY2025 annual report

Employees

76,000 employees — team size stated in the Group CEO profile; the source does not specify a full-time year-end headcount

As disclosed in FY2025 annual report

Registered and business address

Level 35, Mercu Aspire, 3 Jalan Bangsar, KL Eco City, 59200 Kuala Lumpur, Wilayah Persekutuan, Malaysia

Corporate information as at31March2026

Telephone

+603 2201 0138

Corporate information as at31March2026

Fax

+603 2201 0148

Corporate information as at31March2026

Website

www.ihhhealthcare.com

Corporate information as at31March2026

Auditor

KPMG PLT — Chartered Accountants

Corporate information as at31March2026

Auditor office

Level 10, KPMG Tower, 8 First Avenue, Bandar Utama, 47800 Petaling Jaya, Selangor Darul Ehsan, Malaysia

Corporate information as at31March2026

Malaysia share registrar

Boardroom Share Registrars Sdn Bhd; 11th Floor, Menara Symphony, No. 5 Jalan Prof. Khoo Kay Kim, Seksyen 13, 46200 Petaling Jaya, Selangor Darul Ehsan, Malaysia

Corporate information as at31March2026

Singapore share registrar

Boardroom Corporate & Advisory Services Pte Ltd; 1 Harbourfront Avenue, #14-07 Keppel Bay Tower, Singapore 098632

Corporate information as at31March2026

Former director — Lim Tsin-Lin

Resigned on17September2025; excluded from current board count

Corporate information as at31March2026

Roles listed in IHH Healthcare Berhad Annual Report 2025; current appointments are not independently verified.

Holdings

Ownership

Top30 registered row27 prints0.22%, while18,992,184shares divided by8,836,153,463rounds0.21%; the original percentage is retained.

Register date31March2026 differs from financial year end31December2025. Registered nominee blocks and substantial direct/indirect interests are separate disclosures and are not added together.

Employees Provident Fund Board substantial holding is explicitly held through various nominee companies; only nominee beneficiaries explicitly named in the top30 register are displayed. No beneficial owner is inferred for exempt accounts.

Directors’ and Group CEO’s company shareholdings retain the original register names; separate subsidiary shareholdings use subsidiary share capital and are not IHH shares.

Thirty largest registered shareholders — total

7,565,119,759 shares (85.62%)

As at31March2026

MBK Healthcare Management Pte Ltd

Direct: 2,888,487,400 shares (32.69%); indirect: 0 shares (0.00%)

As at31March2026

Mitsui & Co., Ltd

Direct: 0 shares (0.00%); indirect: 2,888,487,400 shares (32.69%)

As at31March2026

Pulau Memutik Ventures Sdn Bhd

Direct: 2,284,536,356 shares (25.85%); indirect: 0 shares (0.00%)

As at31March2026

Khazanah Nasional Berhad

Direct: 0 shares (0.00%); indirect: 2,284,536,356 shares (25.85%)

As at31March2026

Employees Provident Fund Board

Direct: 1,140,645,100 shares (12.91%); indirect: 0 shares (0.00%)

As at31March2026

Mehmet Ali Aydinlar

Direct: 7,948,000 shares (0.09%); indirect: 507,221,573 shares (5.74%)

As at31March2026

Hatice Seher Aydinlar

Direct: 7,000,000 shares (0.08%); indirect: 500,221,573 shares (5.66%)

As at31March2026

SZA Gayrimenkul Yatırım İnşaat ve Ticaret Anonim Sirketi

Direct: 500,221,573 shares (5.66%); indirect: 0 shares (0.00%)

As at31March2026

Shareholding distribution — Less than 100

Holders: 481 (6.08%); shares: 4,975 (0.00%)

As at31March2026

Shareholding distribution — 100 – 1,000

Holders: 2,808 (35.48%); shares: 1,740,692 (0.02%)

As at31March2026

Shareholding distribution — 1,001 – 10,000

Holders: 2,801 (35.39%); shares: 11,955,000 (0.14%)

As at31March2026

Shareholding distribution — 10,001 – 100,000

Holders: 975 (12.32%); shares: 33,906,830 (0.38%)

As at31March2026

Shareholding distribution — 100,001 – 441,807,673 *

Holders: 846 (10.69%); shares: 2,839,939,000 (32.14%)

As at31March2026

Shareholding distribution — 441,807,674 and above **

Holders: 3 (0.04%); shares: 5,948,606,966 (67.32%)

As at31March2026

Shareholding distribution — Total

Holders: 7,914 (100.00%); shares: 8,836,153,463 (100.00%)

As at31March2026

Shareholder category — Individual

Holders: 4,923 (62.21%); shares: 22,794,764 (0.26%)

As at31March2026

Shareholder category — Banks/Finance Companies

Holders: 83 (1.05%); shares: 555,943,118 (6.29%)

As at31March2026

Shareholder category — Investments Trusts/Foundations/Charities

Holders: 4 (0.05%); shares: 139,000 (0.00%)

As at31March2026

Shareholder category — Industrial and Commercial Companies

Holders: 117 (1.48%); shares: 5,173,190,776 (58.55%)

As at31March2026

Shareholder category — Government Agencies/Institutions

Holders: 1 (0.01%); shares: 65,000 (0.00%)

As at31March2026

Shareholder category — Nominees

Holders: 2,785 (35.19%); shares: 3,084,020,803 (34.90%)

As at31March2026

Shareholder category — Others

Holders: 1 (0.01%); shares: 2 (0.00%)

As at31March2026

Shareholder category — Total

Holders: 7,914 (100.00%); shares: 8,836,153,463 (100.00%)

As at31March2026

Issued ordinary shares

8,836,153,463 ordinary shares

As at31March2026

Voting rights

One vote per ordinary share

As at31March2026

Mehmet Ali Aydinlar

Direct: 7,948,000 shares (0.09%); indirect: 507,221,573 shares (5.74%)

As at31March2026

Li Shuling, Christine

Direct: 10,000 shares (0.00%); indirect: 0 shares (0.00%)

As at31March2026

Dr. Prem Kumar Nair

Direct: 778,000 shares (0.01%); indirect: 0 shares (0.00%)

As at31March2026

Mehmet Ali Aydinlar — Acibadem Saglik Yatirimlari Holding A.S.

Direct: 217,211,842 shares (9.28%); indirect: 16,828,159 shares (0.72%); share class: TL1.00 ordinary shares

As at31March2026

Mehmet Ali Aydinlar — Acibadem Saglik Hizmetleri ve Ticaret A.S.

Direct: 1 shares (0.00%); indirect: 1 shares (0.00%); share class: TL1.00 ordinary shares

As at31March2026

Mehmet Ali Aydinlar — Acibadem Proje Yonetimi A.S.

Direct: 1 shares (0.00%); indirect: 0 shares (0.00%); share class: TL1.00 ordinary shares

As at31March2026

Mehmet Ali Aydinlar — Aplus Hastane Otelcilik Hizmetleri A.S.

Direct: 1 shares (0.00%); indirect: 2 shares (0.00%); share class: TL1.00 ordinary shares

As at31March2026

Mehmet Ali Aydinlar — International Hospital Istanbul A.S.

Direct: 1 shares (0.00%); indirect: 1 shares (0.00%); share class: TL2.00 ordinary shares

As at31March2026

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 30 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership.

Registered holderInterestShares / unitsSource
MBK Healthcare Management Pte Ltd2,888,487,400 shares (32.69%)PDF p. 79
Pulau Memutik Ventures Sdn Bhd2,266,086,176 shares (25.65%)PDF p. 79
Citigroup Nominees (Tempatan) Sdn Bhd Employees Provident Fund Board794,033,390 shares (8.99%)PDF p. 79
Citigroup Nominees (Asing) Sdn Bhd UBS Switzerland AG for SZA Gayrimenkul Yatirim Insaat ve Ticaret Anonim Sirketi292,601,573 shares (3.31%)PDF p. 79
Kumpulan Wang Persaraan (Diperbadankan)243,087,500 shares (2.75%)PDF p. 79
Citigroup Nominees (Asing) Sdn Bhd Exempt AN for the Central Depository (Pte) Limited233,875,565 shares (2.65%)PDF p. 79
Citigroup Nominees (Tempatan) Sdn Bhd Employees Provident Fund Board (Islamic)199,071,710 shares (2.25%)PDF p. 79
Citigroup Nominees (Tempatan) Sdn Bhd Exempt AN for AIA Bhd54,122,800 shares (0.61%)PDF p. 79
Lembaga Tabung Haji47,089,500 shares (0.53%)PDF p. 79
HSBC Nominees (Asing) Sdn Bhd JPMCB NA for Vanguard Total International Stock Index Fund45,125,602 shares (0.51%)PDF p. 79
HSBC Nominees (Asing) Sdn Bhd JPMCB NA for Vanguard Emerging Markets Stock Index Fund42,556,035 shares (0.48%)PDF p. 79
HSBC Nominees (Asing) Sdn Bhd Exempt AN for Morgan Stanley & Co. International PLC (IPB CLIENT ACCT)41,329,600 shares (0.47%)PDF p. 79
Maybank Nominees (Tempatan) Sdn Bhd Maybank Trustees Berhad for Public Ittikal Fund (N14011970240)41,000,000 shares (0.46%)PDF p. 79
Amanahraya Trustees Berhad Amanah Saham Bumiputera32,269,100 shares (0.37%)PDF p. 79
Amanahraya Trustees Berhad Amanah Saham Malaysia 328,566,500 shares (0.32%)PDF p. 79
Citigroup Nominees (Tempatan) Sdn Bhd Employees Provident Fund Board (AHAM AM)26,568,400 shares (0.30%)PDF p. 80
Cartaban Nominees (Tempatan) Sdn Bhd Prudential Assurance Malaysia Berhad for Prulink Strategic Fund26,010,700 shares (0.29%)PDF p. 80
Citigroup Nominees (Tempatan) Sdn Bhd Great Eastern Life Assurance (Malaysia) Berhad (PAR 1)24,397,700 shares (0.28%)PDF p. 80
Permodalan Nasional Berhad23,725,300 shares (0.27%)PDF p. 80
HSBC Nominees (Asing) Sdn Bhd JPMCB NA for Vanguard Fiduciary Trust Company Institutional Total International Stock Market Index Trust II22,580,024 shares (0.26%)PDF p. 80
Citigroup Nominees (Tempatan) Sdn Bhd Employees Provident Fund Board (Nomura)20,722,900 shares (0.23%)PDF p. 80
Amanahraya Trustees Berhad Public Ittikal Sequel Fund20,602,200 shares (0.23%)PDF p. 80
Amanahraya Trustees Berhad Public Islamic Dividend Fund20,462,900 shares (0.23%)PDF p. 80
Cartaban Nominees (Tempatan) Sdn Bhd PBTB for Takafulink Dana Ekuiti19,985,200 shares (0.23%)PDF p. 80
Cartaban Nominees (Tempatan) Sdn Bhd PAMB for Prulink Equity Fund19,538,500 shares (0.22%)PDF p. 80
Citigroup Nominees (Tempatan) Sdn Bhd Employees Provident Fund Board (AsianIslamic)19,398,600 shares (0.22%)PDF p. 80
Citigroup Nominees (Asing) Sdn Bhd CBNY for Ishares Core MSCI Emerging Markets ETF18,992,184 shares (0.22%)PDF p. 80
Citigroup Nominees (Tempatan) Sdn Bhd Employees Provident Fund Board (CGS CIMB)17,672,200 shares (0.20%)PDF p. 80
HSBC Nominees (Asing) Sdn Bhd HSBC-FS G for People's Bank of China (SICL ASIA EM)17,660,500 shares (0.20%)PDF p. 80
Maybank Nominees (Tempatan) Sdn Bhd Maybank Trustees Berhad for Public Regular Savings Fund (N14011940100)17,500,000 shares (0.20%)PDF p. 80

Group structure

Subsidiaries, joint ventures and associates

The complete Note38–40 entity lists are retained on their source classifications, including subsidiaries with effective interests below50%, dissolved entities and joint ventures above50%. Percentages alone do not determine control.

The table heading is effective ownership interest and voting interest; FY2025 and FY2024 percentages are retained as printed and are not presented as direct stakes in each subsidiary.

Held-through parent headings are retained with their original source pages. IHH Financial Services and Parkway Vietnam Holdings appear on separate former/current parent rows following disclosed intra-group transfers; the rows are not silently deduplicated.

A dash in FY2025 remains the source dash for transferred, dissolved or liquidated entities; no numeric zero is fabricated. Note38 footnotes explain mixed direct holding percentages and consolidation of special-purpose entities.

CompanyMarketOwnership interest
Integrated Healthcare Holdings LimitedSubsidiary — Note38PDF p. 66 Country: Federal Territory of Labuan Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Company.
Integrated Healthcare Turkey Yatirimlari LimitedSubsidiary — Note38PDF p. 66 Country: Federal Territory of Labuan Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Company.
IHH Financial Services Pte. Ltd.Subsidiary — Note38PDF p. 66 Country: Singapore; effective ownership and voting interest FY2025/FY2024: – / 100%; principal activity: Treasury centre; held through Company.
IHH Laboratories Holdings Sdn. Bhd.Subsidiary — Note38PDF p. 66 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Company.
Parkway Pantai LimitedSubsidiary — Note38PDF p. 66 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Integrated Healthcare Holdings Limited.
Integrated Healthcare Hastaneler Turkey Sdn. Bhd.Subsidiary — Note38PDF p. 66 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Integrated Healthcare Turkey Yatirimlari Limited.
IHH Laboratories Pte. Ltd.Subsidiary — Note38PDF p. 66 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding and provision of services for medical diagnostic laboratory tests; held through IHH Laboratories Holdings Sdn. Bhd..
Pantai Holdings Sdn. Bhd.Subsidiary — Note38PDF p. 66 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Pantai Limited.
Parkway Holdings LimitedSubsidiary — Note38PDF p. 66 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Pantai Limited.
IHH Financial Services Pte. Ltd.Subsidiary — Note38PDF p. 66 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / –; principal activity: Treasury centre; held through Parkway Pantai Limited.
Parkway Healthcare Indo-China Pte. Ltd.Subsidiary — Note38PDF p. 66 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Pantai Limited.
Parkway Group Healthcare Pte. Ltd.Subsidiary — Note38PDF p. 66 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding and provision of technical support services; held through Parkway Pantai Limited.
Parkway HK Holdings LimitedSubsidiary — Note38PDF p. 66 Country: Hong Kong; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Pantai Limited.
Gleneagles Development Pte. Ltd.Subsidiary — Note38PDF p. 66 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Pantai Limited.
Northern TK Venture Pte. Ltd.Subsidiary — Note38PDF p. 66 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Pantai Limited.
Acibadem Saglik Yatirımlari Holding A.S.Subsidiary — Note38PDF p. 66 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 90.00% / 90.00%; principal activity: Investment holding; held through Integrated Healthcare Hastaneler Turkey Sdn. Bhd..
Parkway Laboratory Services Ltd.Subsidiary — Note38PDF p. 66 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of comprehensive diagnostic laboratory services; held through IHH Laboratories Pte. Ltd..
Premier Integrated Labs Sdn. Bhd.Subsidiary — Note38PDF p. 66 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical laboratory services; held through IHH Laboratories Pte. Ltd..
Orifolio Options Sdn. Bhd.Subsidiary — Note38PDF p. 66 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Letting of property; held through Premier Integrated Labs Sdn. Bhd..
APlus Hastane Otelcilik Hizmetleri A.S.Subsidiary — Note38PDF p. 66 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.99% / 89.99%; principal activity: Provision of catering, laundry and cleaning services for hospitals; held through Acibadem Saglik Yatirımlari Holding A.S..
Acibadem Proje Yonetimi A.S.Subsidiary — Note38PDF p. 66 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.99% / 89.99%; principal activity: Supervise and manage the construction of healthcare facilities; held through Acibadem Saglik Yatirımlari Holding A.S..
Acibadem Saglik Hizmetleri ve Ticaret A.S.Subsidiary — Note38PDF p. 66 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Provision of medical, surgical and hospital services; held through Acibadem Saglik Yatirımlari Holding A.S..
Acibadem Poliklinikleri A.S.Subsidiary — Note38PDF p. 66 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Provision of outpatient and surgical (in certain clinics only) services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S..
Acibadem Labmed Saglik Hizmetleri A.S.Subsidiary — Note38PDF p. 66 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Provision of laboratory services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S..
International Hospital İstanbul A.S.Subsidiary — Note38PDF p. 66 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 80.81% / 80.81%; principal activity: Provision of medical, surgical and hospital services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S..
Acibadem Mobil Saglik Hizmetleri A.S.Subsidiary — Note38PDF p. 66 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Provision of emergency, home and ambulatory care services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S..
Clinical Hospital Acibadem Sistina SkopjeSubsidiary — Note38PDF p. 66 Country: Macedonia; effective ownership and voting interest FY2025/FY2024: 48.33% / 48.33%; principal activity: Provision of medical, surgical and hospital services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S..
Acibadem International Medical Center B.V.Subsidiary — Note38PDF p. 66 Country: Netherlands; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Provision of outpatient services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S..
Acibadem Teknoloji A.S.Subsidiary — Note38PDF p. 67 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Conduct research, develop and commercially market healthcare information systems, web-based applications and other technology solutions nationally and internationally; held through Acibadem Saglik Hizmetleri ve Ticaret A.S..
Acibadem City Clinic B.V.Subsidiary — Note38PDF p. 67 Country: Netherlands; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Investment holding; held through Acibadem Saglik Hizmetleri ve Ticaret A.S..
LifeClub Saglikli Yasam Hizmetleri A.S.Subsidiary — Note38PDF p. 67 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 89.79% / 89.79%; principal activity: Provision of e-consulting activities, wellness services and marketplace activities relating to all health-related products and memberships to its subscribers; held through Acibadem Saglik Hizmetleri ve Ticaret A.S..
Bayek Tedavi Saglik Hizmetleri ve Isletmeciligi Anonim SirketiSubsidiary — Note38PDF p. 67 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 71.83% / –; principal activity: Provision of healthcare services; held through Acibadem Saglik Hizmetleri ve Ticaret A.S..
Penta Tip Saglik Hizmetleri Anonim SirketiSubsidiary — Note38PDF p. 67 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 71.83% / –; principal activity: Provision of healthcare services; held through Bayek Tedavi Saglik Hizmetleri ve Isletmeciligi Anonim Sirketi.
Bayek Agiz ve Dis Sagligi Hizmetleri ve Isletmeciligi Anonim SirketiSubsidiary — Note38PDF p. 67 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 71.83% / –; principal activity: Provision of dentalcare services; held through Bayek Tedavi Saglik Hizmetleri ve Isletmeciligi Anonim Sirketi.
Bodrum Medikal Saglik Hizmetleri A.S.Subsidiary — Note38PDF p. 67 Country: Türkiye; effective ownership and voting interest FY2025/FY2024: 53.88% / 53.88%; principal activity: Provision of outpatient services; held through Acibadem Poliklinikleri A.S..
Acibadem Sistina Medikal Kompani Doo SkopjeSubsidiary — Note38PDF p. 67 Country: Macedonia; effective ownership and voting interest FY2025/FY2024: 48.33% / 48.33%; principal activity: Provision of medical equipment and import and wholesale of drug and medical materials; held through Clinical Hospital Acibadem Sistina Skopje.
General Hospital Acibadem Bel MedicSubsidiary — Note38PDF p. 67 Country: Serbia; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Provision of medical, surgical and hospital services; held through Acibadem City Clinic B.V..
Acibadem City Clinic EADSubsidiary — Note38PDF p. 67 Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Investment holding; held through Acibadem City Clinic B.V..
Health Centre Acibadem Bel MedicSubsidiary — Note38PDF p. 67 Country: Serbia; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Provision of medical and general surgical services; held through General Hospital Acibadem Bel Medic.
Bel Food & Coffee d.o.oSubsidiary — Note38PDF p. 67 Country: Serbia; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Provision of services of preparation and serving food; held through General Hospital Acibadem Bel Medic.
Acibadem Bel Medic Logistics D.O.O BeogradSubsidiary — Note38PDF p. 67 Country: Serbia; effective ownership and voting interest FY2025/FY2024: – / 71.13%; principal activity: Liquidated during the year; held through General Hospital Acibadem Bel Medic.
Health Centre Acibadem Bel Medic SlavijaSubsidiary — Note38PDF p. 67 Country: Serbia; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Provision of medical services; held through Health Centre Acibadem Bel Medic.
Acibadem City Clinic University Hospital EOODSubsidiary — Note38PDF p. 67 Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: University multi-profile hospital for acute care; held through Acibadem City Clinic EAD.
Acibadem City Clinic Diagnostic and Consultation Centre EOODSubsidiary — Note38PDF p. 67 Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Outpatient diagnostic and consultative centre; held through Acibadem City Clinic EAD.
Acibadem City Clinic Medical Center Varna EOODSubsidiary — Note38PDF p. 67 Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Outpatient medical centre; held through Acibadem City Clinic EAD.
Acibadem City Clinic Assistance EOODSubsidiary — Note38PDF p. 67 Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Facility management and building maintenance; held through Acibadem City Clinic EAD.
Healthcare Consulting EOODSubsidiary — Note38PDF p. 67 Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Clinical research; held through Acibadem City Clinic EAD.
Tokuda Clinical Research Center ADSubsidiary — Note38PDF p. 67 Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 60.46% / 60.46%; principal activity: Clinical research; held through Acibadem City Clinic EAD.
Acibadem City Clinic Services EOODSubsidiary — Note38PDF p. 67 Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Facility management and building maintenance; held through Acibadem City Clinic EAD.
Tokuda Pharmacy EOODSubsidiary — Note38PDF p. 67 Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Pharmacy; held through Acibadem City Clinic EAD.
Acibadem City Clinic Diagnostic and Consultation Center Tokuda EADSubsidiary — Note38PDF p. 67 Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Outpatient diagnostic and consultative centre; held through Acibadem City Clinic EAD.
Acibadem City Clinic Tokuda University Hospital EADSubsidiary — Note38PDF p. 67 Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Multi-profile hospital for acute care; held through Acibadem City Clinic EAD.
Acibadem City Clinic Mladost EOODSubsidiary — Note38PDF p. 67 Country: Bulgaria; effective ownership and voting interest FY2025/FY2024: 71.13% / 71.13%; principal activity: Provision of construction, hospitality and trade-related services; held through Acibadem City Clinic EAD.
Pantai Group Resources Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Pantai Holdings Sdn. Bhd..
Pantai Hospitals Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding and provision of management and consultation services to hospitals and medical centres; held through Pantai Holdings Sdn. Bhd..
Pantai Management Resources Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Holdings Sdn. Bhd..
Gleneagles (Malaysia) Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Pantai Holdings Sdn. Bhd..
Prince Court Medical Centre Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical, surgical and hospital services; held through Pantai Holdings Sdn. Bhd..
Bedrock Healthcare Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Pantai Holdings Sdn. Bhd..
Island Hospital Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical, surgical and hospital services; held through Pantai Holdings Sdn. Bhd..
Premier Integrated Rehab Sdn. Bhd. (f.k.a. Pantai Integrated Rehab Services Sdn. Bhd.)Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of rehabilitation services; held through Pantai Group Resources Sdn. Bhd..
Pantai Wellness Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of health and wellness services; held through Pantai Group Resources Sdn. Bhd..
Twin Towers Medical Centre KLCC Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Operation of an outpatient and daycare medical centre; held through Pantai Group Resources Sdn. Bhd..
Pantai Medical Centre Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical, surgical and hospital services, as well as providing administrative support, management and consultancy services; held through Pantai Hospitals Sdn. Bhd..
Cheras Medical Centre Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd..
Pantai Klang Specialist Medical Centre Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd..
Syarikat Tunas Pantai Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical, surgical and hospital services; held through Pantai Hospitals Sdn. Bhd..
Paloh Medical Centre Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 95.60% / 95.60%; principal activity: Provision of medical, surgical and hospital services; held through Pantai Hospitals Sdn. Bhd..
Hospital Pantai Ayer Keroh Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd..
Hospital Pantai Indah Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical, surgical and hospital services; held through Pantai Hospitals Sdn. Bhd..
Pantai Hospital Sungai Petani Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd..
Pantai Screening Services Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd..
Gleneagles Hospital (Kuala Lumpur) Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd..
Pantai Hospital Manjung Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Pantai Hospitals Sdn. Bhd..
Pantai Hospital Johor Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Development, construction and leasing of medical facility buildings; held through Pantai Hospitals Sdn. Bhd..
Amanjaya Specialist Centre Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical, surgical and hospital services; held through Pantai Hospitals Sdn. Bhd..
Pulau Pinang Clinic Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 71.88% / 71.88%; principal activity: Provision of hospital services; held through Gleneagles (Malaysia) Sdn. Bhd..
GEH Management Services (M) Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Gleneagles (Malaysia) Sdn. Bhd..
Mestika Unik Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Operation of a specialist medical centre; held through Bedrock Healthcare Sdn. Bhd..
Eminent Rock Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Operation of a specialist medical centre; held through Mestika Unik Sdn. Bhd.
Island Retail Pharmacy Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of retail sale of pharmaceutical, medical and orthopaedic goods; held through Island Hospital Sdn. Bhd..
Coronation Springs Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Property development; held through Island Hospital Sdn. Bhd..
IMC Hospitality Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of hospitality services; held through Island Hospital Sdn. Bhd..
Island Medisuite Sdn. Bhd.Subsidiary — Note38PDF p. 68 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Property development; held through Island Hospital Sdn. Bhd..
Pantai-ARC Dialysis Services Sdn. Bhd.Subsidiary — Note38PDF p. 69 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 51.00% / 51.00%; principal activity: Provision of haemodialysis services; held through Pantai Medical Centre Sdn. Bhd..
Oncology Centre (KL) Sdn. Bhd.Subsidiary — Note38PDF p. 69 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of comprehensive professional oncological services, inclusive of diagnostic, radiotherapy and chemotherapy treatment; held through Pantai Medical Centre Sdn. Bhd..
Parkway Hospitals Singapore Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Private hospitals ownership and management; held through Parkway Holdings Limited.
Parkway Novena Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Development, ownership and management of private hospital premises; held through Parkway Holdings Limited.
Parkway Irrawaddy Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Development, ownership and management of a medical centre; held through Parkway Holdings Limited.
Parkway Shenton Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding and operation of a network of clinics and provision of comprehensive medical and surgical advisory services; held through Parkway Holdings Limited.
Medi-Rad Associates Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Operation of radiology clinics; held through Parkway Holdings Limited.
Gleneagles Medical Holdings LimitedSubsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Holdings Limited.
Parkway College of Nursing and Allied Health Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of courses in nursing and allied health; held through Parkway Holdings Limited.
iXchange Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Agent and administrator for managed care and related services; held through Parkway Holdings Limited.
Parkway Vietnam Holdings Pte. Ltd. (f.k.a. Parkway Shenton International Holdings Pte. Ltd.)Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / –; principal activity: Investment holding; held through Parkway Holdings Limited.
Gleneagles Management Services Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of advisory, administrative, management and consultancy services to healthcare facilities; held through Parkway Holdings Limited.
Parkway Trust Management LimitedSubsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of management services to PLife REIT; held through Parkway Holdings Limited.
Parkway Investments Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Holdings Limited.
Parkway Promotions Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Parkway Hospitals Singapore Pte. Ltd..
Nippon Medical Care Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 70.00% / 70.00%; principal activity: Operation of clinics; held through Parkway Shenton Pte. Ltd..
Parkway Vietnam Holdings Pte. Ltd. (f.k.a. Parkway Shenton International Holdings Pte. Ltd.)Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: – / 100%; principal activity: Investment holding; held through Parkway Shenton Pte. Ltd..
Shenton Family Medical Clinics Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: To provide, establish and carry on the business of clinics; held through Parkway Shenton Pte. Ltd..
Radiology Consultants Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of radiology consultancy and interpretative services; held through Medi-Rad Associates Ltd..
Andaman Alliance Healthcare LimitedSubsidiary — Note38PDF p. 69 Country: Myanmar; effective ownership and voting interest FY2025/FY2024: – / 52.00%; principal activity: Liquidated during the year; held through Parkway Healthcare Indo-China Pte. Ltd..
Parkway-Healthcare (Mauritius) Ltd.Subsidiary — Note38PDF p. 69 Country: Mauritius; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Group Healthcare Pte. Ltd..
Gleneagles International Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Group Healthcare Pte. Ltd..
PCH Holding Pte. Ltd.Subsidiary — Note38PDF p. 69 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Investment holding; held through Parkway Group Healthcare Pte. Ltd..
Shanghai Gleneagles Hospital Management Co., Ltd.Subsidiary — Note38PDF p. 69 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of management and consultancy services to healthcare facilities; held through Parkway Group Healthcare Pte. Ltd..
IHH Technology Sdn. Bhd.Subsidiary — Note38PDF p. 69 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of computer software designing development, customisation, integration, implementation, maintenance and related services; held through Parkway Group Healthcare Pte. Ltd..
Medical Resources International Pte. Ltd.Subsidiary — Note38PDF p. 70 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Investment holding; held through PCH Holding Pte. Ltd..
Parkway (Shanghai) Hospital Management Ltd.Subsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of management and consultancy services to healthcare facilities; held through PCH Holding Pte. Ltd..
M & P Investments Pte. Ltd.Subsidiary — Note38PDF p. 70 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Investment holding; held through PCH Holding Pte. Ltd..
Shanghai Rui Xin Healthcare Co., Ltd.Subsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Medical Resources International Pte. Ltd..
Shanghai Rui Hong Clinic Co., Ltd.Subsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Medical Resources International Pte. Ltd..
Shanghai Xin Rui Healthcare Co., Ltd.Subsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Medical Resources International Pte. Ltd..
Shanghai Shu Kang Hospital Investment Management Co., Ltd.Subsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Investment holding; held through Parkway (Shanghai) Hospital Management Ltd..
Suzhou Industrial Park Yuan Hui Health Consulting Co., Ltd.Subsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Parkway (Shanghai) Hospital Management Ltd..
Shanghai Mai Kang Hospital Investment Management Co., Ltd.Subsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Investment holding; held through Shanghai Shu Kang Hospital Investment Management Co., Ltd..
Chengdu Rui Rong Clinic Co., Ltd.Subsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Shanghai Mai Kang Hospital Investment Management Co., Ltd..
Shanghai Rui Pu Clinic Co., Ltd.Subsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Shanghai Mai Kang Hospital Investment Management Co., Ltd..
Shanghai Rui Xiang Clinic Co., Ltd.Subsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Shanghai Mai Kang Hospital Investment Management Co., Ltd..
Shanghai Rui Ying Clinic Co., Ltd.Subsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 70.10% / 70.10%; principal activity: Provision of medical and healthcare outpatient services; held through Shanghai Mai Kang Hospital Investment Management Co., Ltd..
ParkwayHealth Shanghai Hospital Company LimitedSubsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 49.07% / 49.07%; principal activity: Provision of medical and health related facilities and services; held through M & P Investments Pte. Ltd..
Parkway Healthcare (Hong Kong) LimitedSubsidiary — Note38PDF p. 70 Country: Hong Kong; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of medical and healthcare outpatient services; held through Parkway HK Holdings Limited.
GHK Hospital LimitedSubsidiary — Note38PDF p. 70 Country: Hong Kong; effective ownership and voting interest FY2025/FY2024: 60.00% / 60.00%; principal activity: Private hospital ownership, development and management; held through Parkway HK Holdings Limited.
Parkway Medical Services (Hong Kong) LimitedSubsidiary — Note38PDF p. 70 Country: Hong Kong; effective ownership and voting interest FY2025/FY2024: 60.00% / 60.00%; principal activity: Provision of healthcare services; held through Parkway HK Holdings Limited.
Gleneagles HK International Services (Shenzhen) Co., Ltd.Subsidiary — Note38PDF p. 70 Country: People’s Republic of China; effective ownership and voting interest FY2025/FY2024: 60.00% / –; principal activity: Provision of medical concierge services, regional commercial development and marketing, and seeking partnership opportunities; held through Parkway Medical Services (Hong Kong) Limited.
Parkway Healthcare India Private LimitedSubsidiary — Note38PDF p. 70 Country: India; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Provision of management and consultancy services; held through Gleneagles Development Pte. Ltd..
Gleneagles Healthcare India Pte. Ltd.Subsidiary — Note38PDF p. 70 Country: India; effective ownership and voting interest FY2025/FY2024: 99.15% / 99.15%; principal activity: Private hospital ownership and management, specialty tertiary care including multi organ transplant healthcare facility; held through Gleneagles Development Pte. Ltd..
Centre for Digestive and Kidney Diseases (India) Private LimitedSubsidiary — Note38PDF p. 70 Country: India; effective ownership and voting interest FY2025/FY2024: 64.43% / 64.43%; principal activity: Private hospital ownership and management, specialty tertiary care including multi organ transplant healthcare facility; held through Gleneagles Healthcare India Pte. Ltd..
Gleneagles Clinical Research Services (India) Private LimitedSubsidiary — Note38PDF p. 70 Country: India; effective ownership and voting interest FY2025/FY2024: 99.15% / 99.15%; principal activity: Provision of clinical research services; held through Gleneagles Healthcare India Pte. Ltd..
Fortis Healthcare LimitedSubsidiary — Note38PDF p. 70 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Operates multi-specialty hospitals; held through Northern TK Venture Pte. Ltd..
Hiranandani Healthcare Private LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Operates a multi-specialty hospital; held through Fortis Healthcare Limited.
Fortis Hospotel LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Provision of medical and clinical establishment services; held through Fortis Healthcare Limited.
Adayu Mindfulness LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Investment holding; held through Fortis Healthcare Limited.
Fortis Healthcare International LimitedSubsidiary — Note38PDF p. 71 Country: Mauritius; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Investment holding; held through Fortis Healthcare Limited.
Agilus Diagnostics LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 27.80% / 20.35%; principal activity: Operates a network of diagnostics centres; held through Fortis Healthcare Limited.
Escorts Heart Institute and Research Centre LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Operates a multi-specialty hospital; held through Fortis Healthcare Limited.
Fortis Hospitals LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Operates a network of multi-specialty hospitals; held through Fortis Healthcare Limited.
Fortis CSR FoundationSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Non-profit company for carrying out corporate social responsibilities; held through Fortis Healthcare Limited.
International Hospital LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Provision of medical and clinical establishment services and operates a hospital; held through Fortis Healthcare Limited.
Fortis Health Management LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Provision of medical and clinical establishment services and operates a hospital; held through Fortis Healthcare Limited.
Escorts Heart and Super Speciality Hospital LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Provision of medical and clinical establishment services; held through Fortis Healthcare Limited.
Artistery Properties Private LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Acquires, maintains, improves, develops, and manages land; held through Fortis Healthcare Limited.
Hospitalia Eastern Private LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Provision of medical and clinical establishment services; held through Fortis Health Management Limited.
Agilus Pathlabs Private LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 27.80% / 20.35%; principal activity: Operates a network of diagnostics centres; held through Agilus Diagnostics Limited.
DDRC Agilus Pathlabs LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 27.80% / 20.35%; principal activity: Operates a network of diagnostic centres; held through Agilus Diagnostics Limited.
Agilus Pathlabs Reach LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 27.80% / 20.35%; principal activity: Operates a network of diagnostics centres; held through Agilus Diagnostics Limited.
Agilus Diagnostics FZ-LLCSubsidiary — Note38PDF p. 71 Country: United Arab Emirates; effective ownership and voting interest FY2025/FY2024: 27.80% / 20.35%; principal activity: Operates a network of diagnostics centres; held through Agilus Diagnostics Limited.
Fortis Emergency Services LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Operates ambulance services; held through Fortis Hospitals Limited.
Fortis Cancer Care LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Investment holding; held through Fortis Hospitals Limited.
Fortis Malar Hospitals LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 19.57% / 19.55%; principal activity: Operates a multi-specialty hospital; held through Fortis Hospitals Limited.
Fortis Health Management (East) LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Dormant; held through Fortis Hospitals Limited.
Birdie & Birdie Realtors Private LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Dormant; held through Fortis Hospitals Limited.
Stellant Capital Advisory Services Private LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Merchant banker; held through Fortis Hospitals Limited.
Fortis Global Healthcare (Mauritius) LimitedSubsidiary — Note38PDF p. 71 Country: Mauritius; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Investment holding; held through Fortis Hospitals Limited.
Fortis Asia Healthcare Pte. Ltd.Subsidiary — Note38PDF p. 71 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Investment holding; held through Escorts Heart Institute and Research Centre Limited.
Fortis Health-Staff LimitedSubsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Dormant; held through Escorts Heart Institute and Research Centre Limited.
MENA Healthcare Investment Company LimitedSubsidiary — Note38PDF p. 71 Country: British Virgin Islands; effective ownership and voting interest FY2025/FY2024: 25.73% / 25.73%; principal activity: Investment holding; held through Fortis Asia Healthcare Pte. Ltd..
Medical Management Company LimitedSubsidiary — Note38PDF p. 71 Country: British Virgin Islands; effective ownership and voting interest FY2025/FY2024: 25.73% / 25.73%; principal activity: Investment holding; held through MENA Healthcare Investment Company Limited.
Fortis Healthcare Research Foundation (f.k.a. Malar Stars Medicare Limited)Subsidiary — Note38PDF p. 71 Country: India; effective ownership and voting interest FY2025/FY2024: 19.57% / 19.55%; principal activity: Investment holding; held through Fortis Malar Hospitals Limited.
RHT Health Trust Manager Pte. LimitedSubsidiary — Note38PDF p. 72 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 31.17% / 31.17%; principal activity: Trustee-manager of a business trust; held through Stellant Capital Advisory Services Private Limited.
Parkway Trust Management Japan K.K.Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 100% / –; principal activity: Provision of asset management services; held through Parkway Trust Management Limited.
Gleneagles Medical Centre Ltd.Subsidiary — Note38PDF p. 72 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Parkway Investments Pte. Ltd..
Gleneagles Pharmacy Pte. Ltd.Subsidiary — Note38PDF p. 72 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Dormant; held through Parkway Investments Pte. Ltd..
Mount Elizabeth Medical Holdings LimitedSubsidiary — Note38PDF p. 72 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 100% / 100%; principal activity: Investment holding; held through Parkway Investments Pte. Ltd..
Parkway Life Real Estate Investment TrustSubsidiary — Note38PDF p. 72 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Real estate investment trust; held through Parkway Investments Pte. Ltd..
Parkway Life Japan2 Pte. Ltd.Subsidiary — Note38PDF p. 72 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Real Estate Investment Trust.
Parkway Life Japan3 Pte. Ltd.Subsidiary — Note38PDF p. 72 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Real Estate Investment Trust.
Parkway Life Japan4 Pte. Ltd.Subsidiary — Note38PDF p. 72 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Real Estate Investment Trust.
Parkway Life MTN Pte. Ltd.Subsidiary — Note38PDF p. 72 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Provision of financial and treasury services; held through Parkway Life Real Estate Investment Trust.
Parkway Life Malaysia Pte. Ltd.Subsidiary — Note38PDF p. 72 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Real Estate Investment Trust.
Parkway Life Nova Pte. Ltd.Subsidiary — Note38PDF p. 72 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Real Estate Investment Trust.
Godo Kaisha Del MonteSubsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan2 Pte. Ltd..
Godo Kaisha Tenshi 1Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan2 Pte. Ltd..
Godo Kaisha Tenshi 2Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan2 Pte. Ltd..
G.K. NestSubsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan2 Pte. Ltd..
Godo Kaisha Samurai 19Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan2 Pte. Ltd..
Godo Kaisha Samurai 20Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan2 Pte. Ltd..
Godo Kaisha Healthcare 1Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan3 Pte. Ltd..
Godo Kaisha Healthcare 2Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan3 Pte. Ltd..
Godo Kaisha Healthcare 3Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan3 Pte. Ltd..
Godo Kaisha Healthcare 4Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan3 Pte. Ltd..
Godo Kaisha Healthcare 5Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan3 Pte. Ltd..
Godo Kaisha SamuraiSubsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 2Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 3Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 4Subsidiary — Note38PDF p. 72 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 5Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 6Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 7Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 8Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 9Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 10Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 11Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 12Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 13Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 14Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 15Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 16Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 17Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Godo Kaisha Samurai 18Subsidiary — Note38PDF p. 73 Country: Japan; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Japan4 Pte. Ltd..
Parkway Life Malaysia Sdn. Bhd.Subsidiary — Note38PDF p. 73 Country: Malaysia; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Malaysia Pte. Ltd..
Parkway Life Soleil SASSubsidiary — Note38PDF p. 73 Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Nova Pte. Ltd..
Parkway Life Sante SCSubsidiary — Note38PDF p. 73 Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Nova Pte. Ltd..
Parkway Life Sante 1 SCISubsidiary — Note38PDF p. 73 Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Sante SC.
Parkway Life Sante 2 SCISubsidiary — Note38PDF p. 73 Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Sante SC.
Parkway Life Sante 3 SCISubsidiary — Note38PDF p. 73 Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Sante SC.
Parkway Life Sante 4 SCISubsidiary — Note38PDF p. 73 Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Sante SC.
Parkway Life Sante 5 SCISubsidiary — Note38PDF p. 73 Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Special purpose entity – Investment in real estate; held through Parkway Life Sante SC.
Parkway Life Sante 6 SCISubsidiary — Note38PDF p. 73 Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Sante SC.
Parkway Life Sante 7 SCISubsidiary — Note38PDF p. 73 Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding; held through Parkway Life Sante SC.
Parkway Life Sante 8 SCISubsidiary — Note38PDF p. 73 Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding and special purpose entity – Investment in real estate; held through Parkway Life Sante SC.
Parkway Life Sante 9 SCISubsidiary — Note38PDF p. 73 Country: France; effective ownership and voting interest FY2025/FY2024: 32.94% / 32.95%; principal activity: Investment holding and special purpose entity – Investment in real estate; held through Parkway Life Sante SC.
Champs InvestSubsidiary — Note38PDF p. 74 Country: France; effective ownership and voting interest FY2025/FY2024: – / 32.95%; principal activity: Dissolved during the year; held through Parkway Life Sante 6 SCI.
Saint Marcel InvestSubsidiary — Note38PDF p. 74 Country: France; effective ownership and voting interest FY2025/FY2024: – / 32.95%; principal activity: Dissolved during the year; held through Parkway Life Sante 7 SCI.
Villers-Semeuse InvestSubsidiary — Note38PDF p. 74 Country: France; effective ownership and voting interest FY2025/FY2024: – / 32.95%; principal activity: Dissolved during the year; held through Parkway Life Sante 8 SCI.
SCI TurquoiseSubsidiary — Note38PDF p. 74 Country: France; effective ownership and voting interest FY2025/FY2024: – / 32.95%; principal activity: Dissolved during the year; held through Parkway Life Sante 9 SCI.
PT Tritunggal Sentra Utama SurabayaAssociate — Note39PDF p. 74 Country: Indonesia; effective ownership and voting interest FY2025/FY2024: 30.00% / 30.00%; principal activity: Provision of medical diagnostic services; held through Gleneagles Medical Holdings Limited.
Asia Renal Care Mt Elizabeth Pte. Ltd.Associate — Note39PDF p. 74 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 20.00% / 20.00%; principal activity: Provision of dialysis services and medical consultancy services; held through Gleneagles Medical Holdings Limited.
Asia Renal Care (Katong) Pte. Ltd.Associate — Note39PDF p. 74 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 20.00% / 20.00%; principal activity: Provision of dialysis services and medical consultancy services; held through Gleneagles Medical Holdings Limited.
Positron Tracers Pte. Ltd.Associate — Note39PDF p. 74 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 33.00% / 33.00%; principal activity: Ownership and operation of a cyclotron for production of radioactive tracers; held through Medi-Rad Associates Ltd..
RHT Health TrustAssociate — Note39PDF p. 74 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 8.67% / 8.67%; principal activity: Under members voluntary liquidation; held through Fortis Healthcare International Limited.
The Lanka Hospitals Corporation PLCAssociate — Note39PDF p. 74 Country: Sri Lanka; effective ownership and voting interest FY2025/FY2024: 8.93% / 8.93%; principal activity: Operates a multi-specialty hospital; held through Fortis Asia Healthcare Pte. Ltd..
Gleneagles JPMC Sdn. Bhd. Fortis Healthcare International Limited holds 25.14% RHT Health Trust from RHT Health Trust ManagerAssociate — Note39PDF p. 74 Country: Brunei Darussalam shares in RHT Health Pte. Limited. RHT Heath; effective ownership and voting interest FY2025/FY2024: 30.00% / 30.00%; principal activity: Management and operation of a cardiac and cardiothoracic care centre Trust. In 2025, Fortis Asia Healthcare Pte. Ltd. acquired Trust was delisted from the Official List of the SGX-ST; held through Parkway Holdings Limited.
Apollo Gleneagles PET-CT Private LimitedJoint venture — Note40PDF p. 75 Country: India; effective ownership and voting interest FY2025/FY2024: – / 50.00%; principal activity: Disposed during the year; held through Parkway-Healthcare (Mauritius) Ltd..
Shenton Family Medical Clinic (Ang Mo Kio)Joint venture — Note40PDF p. 75 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 60.00% / 60.00%; principal activity: Operation of medical clinic; held through Shenton Family Medical Clinic Pte. Ltd..
Shenton Family Medical Clinic (Bedok Reservoir)Joint venture — Note40PDF p. 75 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 62.50% / 62.50%; principal activity: Operation of medical clinic; held through Shenton Family Medical Clinic Pte. Ltd..
Shenton Family Medical Clinic (Duxton)Joint venture — Note40PDF p. 75 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 50.00% / 50.00%; principal activity: Operation of medical clinic; held through Shenton Family Medical Clinic Pte. Ltd..
Shenton Family Medical Clinic (Tampines)Joint venture — Note40PDF p. 75 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 50.00% / 50.00%; principal activity: Operation of medical clinic; held through Shenton Family Medical Clinic Pte. Ltd..
Shenton Family Medical Clinic (Towner)Joint venture — Note40PDF p. 75 Country: Singapore; effective ownership and voting interest FY2025/FY2024: 50.00% / 50.00%; principal activity: Operation of medical clinic; held through Shenton Family Medical Clinic Pte. Ltd..
Agilus Diagnostics (Nepal) Pvt. Ltd.Joint venture — Note40PDF p. 75 Country: Nepal; effective ownership and voting interest FY2025/FY2024: 13.90% / 10.18%; principal activity: Operates a network of diagnostics centres; held through Agilus Diagnostics Limited.
Fortis C-Doc Healthcare LimitedJoint venture — Note40PDF p. 75 Country: India; effective ownership and voting interest FY2025/FY2024: 18.70% / 18.70%; principal activity: Operates a hospital; held through Fortis Hospitals Limited.
Fortis Cauvery (Partnership Firm)Joint venture — Note40PDF p. 75 Country: India; effective ownership and voting interest FY2025/FY2024: 15.90% / 15.90%; principal activity: Under members voluntary liquidation; held through Fortis Cancer Care Limited.
Uniglo Enterprise Sdn. Bhd. The Group has accounted for the entity as a joint the joint venture partner.Joint venture — Note40PDF p. 75 Country: Malaysia venture in accordance with; effective ownership and voting interest FY2025/FY2024: 50.00% / 50.00%; principal activity: Operation of an Eye Specialist Clinic MFRS on the basis that the entity’s operating decisions; held through Bedrock Healthcare Sdn. Bhd..

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
Seow Ching Voon COMPANY SECRETARY As at 31 March 2026 · As at 2026-03-31 PDF p. 86

Extracted from IHH Healthcare Berhad Annual Report 2025 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

ItemValuePeriod / scopeSource
Issued share capital 8,836,153,463 ordinary shares As at 31 March 2026 · As at 2026-03-31 PDF p. 78
Class of securities Ordinary shares As at 31 March 2026 · As at 2026-03-31 PDF p. 78
Voting right One vote per ordinary share As at 31 March 2026 · As at 2026-03-31 PDF p. 78

Shareholding distribution

ItemValuePeriod / scopeSource
Total 7,914 shareholders Distribution of shareholdings, total shareholders · As at 2026-03-31 PDF p. 78
Less than 100 481 holders; 6.08% of holders; 4,975 shares; 0.00% of shares Size of shareholdings · As at 2026-03-31 PDF p. 78
100 – 1,000 2,808 holders; 35.48% of holders; 1,740,692 shares; 0.02% of shares Size of shareholdings · As at 2026-03-31 PDF p. 78
1,001 – 10,000 2,801 holders; 35.39% of holders; 11,955,000 shares; 0.14% of shares Size of shareholdings · As at 2026-03-31 PDF p. 78
10,001 – 100,000 975 holders; 12.32% of holders; 33,906,830 shares; 0.38% of shares Size of shareholdings · As at 2026-03-31 PDF p. 78
100,001 – 441,807,673 * 846 holders; 10.69% of holders; 2,839,939,000 shares; 32.14% of shares Size of shareholdings · As at 2026-03-31 PDF p. 78
441,807,674 and above ** 3 holders; 0.04% of holders; 5,948,606,966 shares; 67.32% of shares Size of shareholdings · As at 2026-03-31 PDF p. 78

Extracted from IHH Healthcare Berhad Annual Report 2025 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
Sales and provision of services 1 RM'mil Group, with substantial shareholders (incl. parties controlled by them), 2025 PDF p. 62
Purchases and consumption of services (26) RM'mil Group, with substantial shareholders (incl. parties controlled by them), 2025 PDF p. 62
Sales and provision of services 10 RM'mil Group, with associates and joint ventures, 2025 PDF p. 62
Sales and provision of services 11 RM'mil Group, with key management personnel (incl. parties controlled by them), 2025 PDF p. 62
Purchases and consumption of services (182) RM'mil Group, with key management personnel (incl. parties controlled by them), 2025 PDF p. 62
Khazanah Nasional Berhad (KNB) 25.85% Related party by virtue of substantial shareholding in the Company, 2025 (2024: 25.92%) PDF p. 61
RECURRENT RELATED PARTY TRANSACTIONS did not exceed the threshold prescribed Group, FY2025 PDF p. 77

Contingent liabilities

ItemValuePeriod / scopeSource
41. CONTINGENT LIABILITIES (a) INR7 billion (equivalent to RM325 million) Group, as at 31 December 2025 · As at 2025-12-31 PDF p. 75

Director remuneration

ItemValuePeriod / scopeSource
Non-executive directors: − Fees 8 RM'mil Group, 2025 (2024: 7) PDF p. 47
Non-executive directors: − Fees 5 RM'mil Company, 2025 (2024: 3) PDF p. 47
Board of Directors 825,000 RM per annum Proposed Chairman fee, 1 July 2026 to 30 June 2027 PDF p. 81

Properties

ItemValuePeriod / scopeSource
Mount Elizabeth Novena Hospital Leasehold 2108 N/A Strata Hospital 12 4,425 a Singapore; 38 Irrawaddy Road, Singapore 329563; Leasehold land and building; hospital and medical centre units PDF p. 80
Mount Elizabeth Hospital Leasehold 2075 N/A Strata Hospital 46 1,595 a,b Singapore; 3 Mount Elizabeth, Singapore 228510; Leasehold land and building; hospital and medical centre units PDF p. 80
Gleneagles Hospital Freehold – N/A Strata Hospital 34 827 a,b Singapore; 6 Napier Road, Singapore 258499; 6A Napier Road, Singapore 258500; Freehold land and building; hospital and medical centre units PDF p. 80
Island Hospital Leasehold 2119 44,844 Built-up Hospital 23 years for 855 c Malaysia; No. 308, Macalister Road, 10450 George Town, Penang; Leasehold and freehold land and building PDF p. 80
Prince Court Medical Centre Leasehold 2103 29,108 Built-up Hospital 18 678 d Malaysia; 39 Jalan Kia Peng, 50450 Kuala Lumpur; Leasehold land and building PDF p. 80
Gleneagles Hospital Medini Johor Leasehold 2107 80,497 Built-up Hospital 10 347 a Malaysia; No. 2, Jalan Medini Utara 4, Medini Iskandar, 79250 Iskandar Puteri, Johor; Leasehold land and building PDF p. 80
Parkway Shanghai Hospital Leasehold 2066 35,754 Built-up Hospital 2 326 China; No.1172, JiLe Road, Minhang District, Shanghai; Leasehold land and building PDF p. 81
Gleneagles Hospital Hong Kong Leasehold 2063 27,500 Built-up Hospital 8 1,702 Hong Kong; 1 Nam Fung Path, Wong Chu Hang; Leasehold land and building PDF p. 81
Acibadem Kent Hospital Freehold – 35,000 Built-up Hospital <1 1,027 Türkiye; Bayrakli/Izmir; Freehold land and building PDF p. 81
Acibadem Kartal Hospital Freehold – 4,665 Built-up Hospital <1 372 Türkiye; Kartal-Istanbul; Freehold land and building PDF p. 81

Subsequent events

ItemValuePeriod / scopeSource
43. SUBSEQUENT EVENT (a) On 9 January 2026, IHL completed the acquisition of 100% equity stake in TMI Healthcare Private Limited (“THPL”) for a total Group · As at 2026-01-09 PDF p. 76
43. SUBSEQUENT EVENT (b) On 20 January 2026, the shareholders of IHH approved the IHH Long-Term Incentive Plan (“LTIP”) at its extraordinary general Company · As at 2026-01-20 PDF p. 76
43. SUBSEQUENT EVENT (c) On 19 February 2026, PLife REIT issued 166,139 new PLife REIT units being part payment of base fee component of the Group · As at 2026-02-19 PDF p. 76

Extracted from IHH Healthcare Berhad Annual Report 2025 and checked against the cited pages; see the original report for full context.

Source: IHH Healthcare Berhad Annual Report 2025 ↗

Corporate information

Registration & contacts

Incorporated In
MALAYSIA
Incorporated On
21 May 2010
Email
[email protected]
Telephone
+603 22010138
Fax
+603 22010148
Registered Office
Level 35, Mercu Aspire
3 Jalan Bangsar, KL Eco City
59200 Kuala Lumpur
Wilayah Persekutuan Malaysia
Secretary
Seow Ching Voon
Registrar / Transfer Agent
BOARDROOM SHARE REGISTRARS SDN BHD \
BOARDROOM CORPORATE & ADVISORY SERVICES PTE. LTD.
Registrar Address
11 Floor, Menara Symphony, No. 5, Jalan Prof. Khoo Kay Kim, Seksyen 13, 46200 Petaling Jaya, Selangor, Malaysia/1 Harbourfront Avenue, Keppel Bay Tower, #14-07, Singapore 098632
Auditors
KPMG PLT
Other Stock Exchange Listings
BURSA MALAYSIA
Country
MALAYSIA
Security Type
stocks